TWST - Company ID 0001581280
The table below shows Twist Bioscience Corp's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $183.05M | $226.32M | $286.47M | $378.69M | $465.83M | $93.67M |
| Short-term investments | $49.38M | $50.08M | $49.94M | $126.28M | $12.03M | $196.34M |
| Receivables | $57.02M | $34.90M | $44.06M | $40.29M | $28.55M | $26.38M |
| Inventory | $28.31M | $24.08M | $32.06M | $39.31M | $31.80M | $12.29M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $332.97M |
| $346.78M |
| $424.26M |
| $596.48M |
| $546.50M |
| $334.87M |
| Property, plant & equipment | $102.28M | $102.52M | $131.83M | $139.44M | $44.12M | $25.47M |
| Goodwill | $82.19M | $85.81M | $85.81M | $85.81M | $22.43M | $1.14M |
| Total assets | $641.86M | $614.32M | $776.40M | $961.38M | $702.10M | $398.88M |
| Accounts payable | $11.09M | $1.63M | $14.05M | $20.09M | $14.90M | $4.83M |
| Total current liabilities | $91.41M | $71.01M | $73.32M | $90.66M | $63.05M | $36.03M |
| Long-term debt | - | - | - | - | $1.40M | $1.40M |
| Total liabilities | $168.90M | $141.63M | $152.97M | $171.99M | $121.28M | $62.62M |
| Retained earnings | -$1.32B | -$1.24B | -$1.03B | -$828.42M | -$610.55M | -$458.45M |
| Total equity | $472.96M | $472.69M | $623.43M | $789.38M | $580.82M | $336.26M |